Ochre Bio Appoints Eliot Forster, Ph.D. as Chairperson of its Board of Directors

OXFORD, England–(BUSINESS WIRE)–Ochre Bio, an innovator in chronic liver disease medicine development, today announced the appointment of Eliot Forster, Ph.D. as Chairperson of the Board of Directors. With decades of experience in pharmaceutical and biotechnology industries, cofounding and leading several companies Dr. Forster has successfully raised more than $550M in…